Bloom Energy Corporation
BE · NYSE
Analyst ratings
buy · 19 ratings
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| July 10, 2026 | Susquehanna | Maintains | Positive | $298.00 |
| July 9, 2026 | Baird | Reiterates | Outperform | $310.00 |
| July 6, 2026 | Jefferies | Maintains | Hold | $246.00 |
| July 1, 2026 | UBS | Maintains | Buy | $350.00 |
| July 1, 2026 | Roth Capital | Maintains | Neutral | $285.00 |
| July 1, 2026 | Evercore ISI Group | Maintains | Outperform | $350.00 |
| June 23, 2026 | Barclays | Maintains | Equal-Weight | $276.00 |
| May 12, 2026 | Barclays | Maintains | Equal-Weight | $254.00 |
| April 30, 2026 | Citigroup | Maintains | Neutral | $281.00 |
| April 29, 2026 | JP Morgan | Maintains | Overweight | $267.00 |
| April 29, 2026 | TD Cowen | Maintains | Hold | $235.00 |
| April 29, 2026 | RBC Capital | Maintains | Outperform | $335.00 |
| April 29, 2026 | Wells Fargo | Maintains | Equal-Weight | $217.00 |
| April 29, 2026 | Susquehanna | Maintains | Positive | $293.00 |
| April 29, 2026 | BTIG | Maintains | Buy | $295.00 |
| April 27, 2026 | Barclays | Maintains | Equal-Weight | $177.00 |
| April 22, 2026 | Baird | Maintains | Outperform | $242.00 |
| April 21, 2026 | UBS | Maintains | Buy | $251.00 |
| April 21, 2026 | Citigroup | Maintains | Neutral | $229.00 |
| April 14, 2026 | Jefferies | Upgrades | Hold | $187.00 |
| April 14, 2026 | JP Morgan | Maintains | Overweight | $231.00 |
| April 9, 2026 | Susquehanna | Maintains | Positive | $173.00 |
| March 27, 2026 | Jefferies | Maintains | Underperform | $97.00 |
| February 9, 2026 | Mizuho | Maintains | Neutral | $110.00 |
| February 6, 2026 | JP Morgan | Maintains | Overweight | $166.00 |
| February 6, 2026 | BMO Capital | Maintains | Market Perform | $149.00 |
| February 6, 2026 | Wells Fargo | Maintains | Equal-Weight | $130.00 |
| February 6, 2026 | Morgan Stanley | Maintains | Overweight | $184.00 |
| February 6, 2026 | BTIG | Maintains | Buy | $165.00 |
| February 3, 2026 | Roth Capital | Maintains | Neutral | $133.00 |
| December 29, 2025 | Clear Street | Maintains | Hold | $58.00 |
| November 25, 2025 | B of A Securities | Maintains | Underperform | $39.00 |
| October 30, 2025 | Morgan Stanley | Maintains | Overweight | $155.00 |
| October 29, 2025 | HSBC | Upgrades | Buy | $150.00 |
| October 29, 2025 | JP Morgan | Maintains | Overweight | $129.00 |
| October 29, 2025 | Susquehanna | Maintains | Positive | $157.00 |
| October 29, 2025 | BTIG | Maintains | Buy | $145.00 |
| October 21, 2025 | Wells Fargo | Maintains | Equal-Weight | $95.00 |
| October 20, 2025 | B of A Securities | Maintains | Underperform | $26.00 |
| October 14, 2025 | BMO Capital | Maintains | Market Perform | $97.00 |
| October 14, 2025 | UBS | Maintains | Buy | $115.00 |
| October 13, 2025 | Susquehanna | Maintains | Positive | $105.00 |
| October 9, 2025 | HSBC | Downgrades | Hold | $100.00 |
| October 2, 2025 | Mizuho | Downgrades | Neutral | $79.00 |
| October 2, 2025 | JP Morgan | Maintains | Overweight | $90.00 |
| September 29, 2025 | BTIG | Maintains | Buy | $80.00 |
| September 24, 2025 | Jefferies | Downgrades | Underperform | $31.00 |
| September 23, 2025 | B of A Securities | Maintains | Underperform | $24.00 |
| September 19, 2025 | Roth Capital | Maintains | Neutral | $73.00 |
| September 19, 2025 | UBS | Maintains | Buy | $105.00 |
| September 16, 2025 | Morgan Stanley | Maintains | Overweight | $85.00 |
| September 12, 2025 | Wells Fargo | Maintains | Equal-Weight | $65.00 |
| September 11, 2025 | RBC Capital | Maintains | Outperform | $75.00 |
| September 4, 2025 | Baird | Maintains | Outperform | $61.00 |
Valuation relative to fundamentals and analyst consensus
The market's premium pricing reflects an underappreciated growth inflection. With Q1 2026 revenue surging 130% year-over-year to $751 million, adjusted EPS of $0.44 vastly beating the $0.12 consensus, and management raising full-year EPS guidance to $1.85–$2.25, the stock's elevated valuation is seen as justified by accelerating fundamentals and order momentum.
Trading above $329 — well above the Wall Street average target of ~$263 — Bloom Energy leaves no margin of error. At roughly 140x the low end of forward EPS guidance, Morningstar flags the stock as highly overvalued, and Jefferies maintained only a Hold rating with a $246 target, reflecting deep skepticism about whether current pricing can be sustained.
Scandium supply chain vulnerability and Chinese export risk
Bloom Energy has firmly denied reliance on any single source of scandium, citing a diversified and robust global supply network. UBS characterized raw material concerns as overblown, maintaining its Buy rating and raising its price target to $350, while RBC argued that short sellers are getting the supply-chain thesis wrong.
A short-seller report from Hunterbrook alleged that Bloom Energy is critically dependent on Chinese-sourced scandium oxide for its fuel cells, warning that any Chinese export restriction could severely constrain production and growth. Crossroads Capital also holds a short position, amplifying concerns ahead of the Q2 earnings report.
Sustainability of AI data center demand as a long-term growth driver
A $25 billion financing deal with Brookfield to deploy Bloom fuel cells for Nebius' AI infrastructure, combined with a landmark FERC regulatory decision and Morgan Stanley's note on AI data center demand fueling a clean tech order inflection, positions Bloom as the default on-site power solution for the AI buildout cycle.
Investors have shown growing anxiety that AI infrastructure demand may not translate as smoothly into revenue as expected. Bloom's sharp 18% single-day plunge in late June and a subsequent selloff reflected fears that its valuation has run well ahead of what AI-driven demand can realistically deliver in the near term.